Table 1 Descriptive information on infants diagnosed with E. coli bloodstream or cerebrospinal fluid infection from 2008 to 2022.
From: Predictors of mortality and severe illness from Escherichia coli sepsis in neonates
Demographic/clinical characteristic | |
|---|---|
Median GA in weeks (IQR) | 31 2/7 (27 4/7 – 38 0/7) |
Median BW in grams (IQR) | 1620 (970–2835) |
Sex, N (%) | |
Female Male | 25 (37%) 43 (63%) |
Race, N (%) | |
Black White Other | 37 (54.4%) 28 (41.2%) 3 (4.4%) |
Delivery type, N (%) | |
Vaginal Cesarean section | 47 (69.1%) 21 (30.9%) |
Inborn Neonates | 53/68 (78%) |
Maternal IAI | 20/68 (29.4%) |
Median hours of life at which blood culture was obtained (IQR) | 31.5 (1.9–173.8) |
Ampicillin resistance, N (%) | 48/67 (71.6%) |
Gentamicin resistance, N (%) | 6/67 (8.9%) |
Mortality | 17/68 (25%) |
Need for inotropic medication or severe metabolic acidosis | 37/68 (54%) |
Median days of antibiotics in all infants (IQR) | 16 (13–21) |
Median days of antibiotics in infants who survived (IQR) | 21 (14–21) |
